Aureus Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-1,820
| Closed | -$204K | – | 236 |
|
2021
Q4 | $204K | Hold |
1,820
| – | – | 0.01% | 201 |
|
2021
Q3 | $229K | Hold |
1,820
| – | – | 0.02% | 191 |
|
2021
Q2 | $246K | Hold |
1,820
| – | – | 0.02% | 196 |
|
2021
Q1 | $247K | Hold |
1,820
| – | – | 0.02% | 158 |
|
2020
Q4 | $256K | Hold |
1,820
| – | – | 0.02% | 162 |
|
2020
Q3 | $203K | Hold |
1,820
| – | – | 0.02% | 170 |
|
2020
Q2 | $204K | Buy |
+1,820
| New | +$204K | 0.02% | 160 |
|
2020
Q1 | – | Sell |
-2,910
| Closed | -$277K | – | 178 |
|
2019
Q4 | $277K | Hold |
2,910
| – | – | 0.03% | 151 |
|
2019
Q3 | $222K | Hold |
2,910
| – | – | 0.03% | 157 |
|
2019
Q2 | $255K | Hold |
2,910
| – | – | 0.03% | 156 |
|
2019
Q1 | $263K | Hold |
2,910
| – | – | 0.03% | 148 |
|
2018
Q4 | $209K | Hold |
2,910
| – | – | 0.03% | 159 |
|
2018
Q3 | $279K | Hold |
2,910
| – | – | 0.04% | 157 |
|
2018
Q2 | $277K | Hold |
2,910
| – | – | 0.04% | 159 |
|
2018
Q1 | $255K | Hold |
2,910
| – | – | 0.04% | 155 |
|
2017
Q4 | $247K | Hold |
2,910
| – | – | 0.04% | 160 |
|
2017
Q3 | $252K | Hold |
2,910
| – | – | 0.04% | 158 |
|
2017
Q2 | $225K | Hold |
2,910
| – | – | 0.04% | 149 |
|
2017
Q1 | $201K | Buy |
+2,910
| New | +$201K | 0.03% | 178 |
|
2016
Q1 | – | Sell |
-2,910
| Closed | -$204K | – | 149 |
|
2015
Q4 | $204K | Buy |
+2,910
| New | +$204K | 0.05% | 139 |
|
2015
Q3 | – | Sell |
-2,910
| Closed | -$245K | – | 176 |
|
2015
Q2 | $245K | Hold |
2,910
| – | – | 0.05% | 145 |
|
2015
Q1 | $219K | Buy |
+2,910
| New | +$219K | 0.05% | 138 |
|